Related Experiment Video
Updated: Feb 14, 2026
Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
AX-2: A Promising Non-Hemolytic Protein of Bacillus thuringiensis with Potent Selective Cytotoxicity Against Breast
Alain Cruz-Nolasco1, Miguel Angel Peña-Rico2, Sibel J Estrada-Escobedo3
1División de Estudios de Posgrado, Doctorado en Biotecnología, Universidad del Papaloapan, Circuito Central 200, Parque Industrial, Tuxtepec 68301, Oaxaca, Mexico.
Abstract:
Conventional cancer therapies often harm healthy tissues due to their poor specificity, resulting in significant side effects that diminish patients' quality of life. Parasporins, a group of non-hemolytic parasporal proteins produced by Bacillus thuringiensis, are known for their selective cytotoxicity toward cancer cells. Typically, these proteins require activation through physical or biochemical treatments that fragment them into multiple peptides of varying sizes, which are then tested as mixtures, without purification, against cancer cell lines. In this study, a purification strategy that isolates the protein without prior activation and evaluates the resulting cytotoxic mechanism is proposed. The purification consists of four steps: (1) crystal solubilization with Laemmli buffer, (2) size-based separation via SDS-PAGE, (3) electroelution of the target protein from the gel, and (4) dialysis to remove the elution buffer. From the B. thuringiensis AX isolate, four proteins ranging from ~20 to 60 kDa were recovered, but only AX-2 displayed cytotoxic activity toward MCF-7 breast cancer cells, while remaining non-hemolytic and non-toxic to normal cells (erythrocytes, PBMCs, and MRC-5 fibroblasts). Thus, AX-2 qualifies as a parasporin. AX-2 induces apoptosis in MCF-7 breast cancer cells without generating oxidative stress, and the observed cell death appears to initiate at the plasma membrane rather than through intracellular pathways.
Insights
A novel purification method isolated AX-2, a selective cancer-fighting protein from Bacillus thuringiensis. This parasporin kills breast cancer cells via apoptosis without harming healthy cells or causing oxidative stress.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Conventional cancer therapies lack specificity, causing severe side effects.
- Parasporins from Bacillus thuringiensis show selective cancer cell toxicity.
- Existing methods test unpurified protein mixtures after activation.
Purpose of the Study:
- To develop a purification strategy for isolating active parasporins.
- To characterize the cytotoxic mechanism of purified parasporins.
- To evaluate the specificity and safety of potential cancer therapeutics.
Main Methods:
- Purification of Bacillus thuringiensis AX isolate proteins using Laemmli buffer, SDS-PAGE, electroelution, and dialysis.
- Assessment of cytotoxic activity against MCF-7 breast cancer cells.
- Evaluation of hemolytic and general toxicity toward erythrocytes, PBMCs, and MRC-5 fibroblasts.
- Apoptosis induction and oxidative stress assays.
Main Results:
- Four proteins were isolated, with AX-2 exhibiting selective cytotoxicity.
- AX-2 demonstrated potent activity against MCF-7 cells.
- AX-2 showed no hemolytic or general toxicity to normal cells.
- AX-2 induced apoptosis in cancer cells, initiating at the plasma membrane without oxidative stress.
Conclusions:
- The developed purification strategy successfully isolated an active parasporin, AX-2.
- AX-2 is a promising candidate for targeted breast cancer therapy due to its specificity and safety profile.
- AX-2's unique mechanism of action, inducing apoptosis via plasma membrane interaction, warrants further investigation.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:22T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
01:32What is Natural Selection?
00:57Antibiotic Selection
01:46Types of Selection
01:21Frequency-dependent Selection